Efficacy and Tolerability of Second-line Pembrolizumab With Radiation Therapy in Advanced Urothelial Carcinoma. Sano T, Aizawa R, Ito K, Nakamura K, et al. Anticancer Res 2023;43:2119-2126.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sano T, Aizawa R, Ito K, Nakamura K, et al. Efficacy and Tolerability of Second-line Pembrolizumab With Radiation Therapy in Advanced Urothelial Carcinoma. Anticancer Res 2023;43:2119-2126.
PMID: 37097696